Opdivo Boosts Survival In Head And Neck Cancer Patients For 12 Months
The US based pharma giant “Bristol Myers Squibb’s (BMS)” Opdivo seems to be on its way towards acceptance in yet
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine